HBI Deals+Insights / News
Michael Sen, the new CEO of Fresenius SE, was previously hired back by Siemens to lead the break up IPO of Siemens Healthineers. So will Sen, currently the CEO of Fresenius’ infusion, transfusion and clinical nutrition subsidiary Kabi, be for revolution or continuity?